Keywords: Coronada Biosciences, Dr Falk Pharma, OvaMed, Crohn's disease, TSO

Coronado Biosciences gets rights from Dr Falk and OvaMed for TSO

Article | 23 March 2012

Print This

US biopharma company Coronado Biosciences (Nasdaq: CNDO) has signed a collaboration agreement with German drugmakers Dr Falk Pharma GmbH and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in